The effects of Danggui-Buxue-Tang on blood lipid and expression of genes related to foam cell formation in the early stage of atherosclerosis in diabetic GK rats

Diabetes Research and Clinical Practice

Volumn 77, Issue 3, 2007, Pages 479-481

  Zhang, Hongmin ^a   Chen, Shiwei ^b   Deng, Xifang ^c   Yang, Xuguang ^c   Huang, Xi ^a  

^a SICHUAN UNIVERSITY   (China)

^b Henan Province Food and Drug Administration   (China)

^c CHENGDU UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

Author keywords

Blood lipid; CD36; Danggui Buxue Tang; Diabetic atherosclerosis; Intercellular adhesion molecule 1; Monocyte chemoattractant protein 1

Indexed keywords

CD36 ANTIGEN; CHINESE DRUG; DANGGUI BUXUE TANG; DRINKING WATER; HERBACEOUS AGENT; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INTERCELLULAR ADHESION MOLECULE 1; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; N(G) NITROARGININE METHYL ESTER; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CHINESE MEDICINE; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC ANGIOPATHY; DRUG DOSE COMPARISON; DRUG EFFECT; DRUG MEGADOSE; FOAM CELL; GENE EXPRESSION; HERBAL MEDICINE; LIPID BLOOD LEVEL; LIPID DIET; LOW DRUG DOSE; MACROPHAGE; NONHUMAN; RAT; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRADITIONAL MEDICINE; TREATMENT OUTCOME;

ANIMALS; ANTIGENS, CD36; ATHEROSCLEROSIS; CHEMOKINE CCL2; DIABETES MELLITUS, EXPERIMENTAL; DRUGS, CHINESE HERBAL; FOAM CELLS; GENE EXPRESSION REGULATION; INTERCELLULAR ADHESION MOLECULE-1; LIPIDS; PLANT EXTRACTS; RATS; RNA, MESSENGER;

EID: 34547687938     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2006.11.005     Document Type: Article

References (10)

1. Beverly L.E., Cohen J.D., Prineas R., and Yang L. Impact of incident diabetes and incident nonfatal cardiovascular disease on 18-year mortality: the Multiple Risk Factor Intervention Trial experience. Diabetes Care 26 (2003) 848-854
2. Clark Jr. C.M., Fradkin J.E., Hiss R.G., Lorenz R.A., Vinicor F., and Warren-Boulton E. The National Diabetes Education Program, changing the way diabetes is treated: comprehensive diabetes care. Diabetes Care 24 (2001) 617-618
3. Gaede P., Vedel P., Larsen N., Jensen G.V., Parving H.H., and Pedersen O. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. New Engl. J. Med. 348 (2003) 383-393
4. Li W.L., Zheng H.C., Bukuru J., and De Kimpe N. Natural medicines used in the traditional Chinese medical system for therapy of diabetes mellitus. J. Ethnopharmacol. 92 (2004) 1-21
5. Huang S.Q., Wang B., Wang J., Gao L., Zhang Y.B., and Yan C. Experiment on antiatherosis effect of Daguibuxue Decoction in rabbits. Beijing Zhong Yi Yao Da Xue Xue Bao 28 (2005) 140-144 (in Chinese)
6. Zhang H.M., Chen S.W., Deng X.F., Yang X.G., and Huang X. Danggui-Buxue-Tang decoction has an anti-inflammatory effect in diabetic atherosclerosis rat model. Diabetes Res. Clin. Pr. 74 (2006) 194-196
7. Luc G., and Fruchart J.C. Oxidation of lipoproteins and atherosclerosis. Am. J. Clin. Nutr. 53 (1991) 206S-209S
8. Huo Y., and Ley K. Adhesion molecules and atherogenesis. Acta Physiol. Scand. 173 (2001) 35-43
9. Kunjathoor V.V., Febbraio M., Podrez E.A., Moore K.J., Andersson L., Koehn S., et al. Scavenger receptors class A-I/II and CD36 are the principal receptors responsible for the uptake of modified lowdensity lipoprotein leading to lipid loading in macrophages. J. Biol. Chem. 277 (2002) 49982-49988
10. Nicholson A.C. Expression of CD36 in macrophages and atherosclerosis: the role of lipid regulation of PPARgamma signaling. Trends Cardiovas. Med. 14 (2004) 8-12